Nicolas is a BioScience Engineer by training holding a PhD in microfluidics and diagnostics. He has a broad interest and experience in the domains of qPCR, next-generation sequencing, immunoassays and data analytics, and a passion for transitioning novel technologies into high-impact diagnostics that improve clinical decision taking for the patient's benefit in various diagnostics fields like oncology and infectious diseases.
Nicolas joined miDIAGNOSTICS as CEO in April 2018. In this capacity, Nicolas and his team will develop and extend the miDIAGNOSTICS product portfolio by building further on the groundbreaking research of Imec and Johns Hopkins University. Until March 2018, Nicolas was Vice President Innovations at Biocartis, a molecular diagnostics company that has developed a sample-to-result platform for oncology and infectious disease applications. As VIP Innovations, Nicolas was responsible for bringing novel technologies and assay concepts to the market.
Beyond the limitations of point-of-care testing: opportunities for a new platform concept
Antwerp Management School & Accenture Strategy